A bent penis isn’t just a cosmetic worry, and new urology guidance makes clear the fix depends entirely on timing.
Quick Take
- Peyronie’s disease treatment now follows a clear two-phase roadmap set by the American Urological Association (AUA).
- Collagenase injections are approved for men with stable disease, curvature between 30 and 90 degrees, and working erectile function.
- The Food and Drug Administration (FDA) restricts the drug through a special safety program because of rare but serious injury risk.
- Surgery stays off the table until the condition stops changing, which usually takes 12 to 18 months.
Why Doctors Wait Before Operating
Peyronie’s disease causes scar tissue to build under the skin of the penis, bending it during erections. The AUA guideline says men should not get surgery until their disease reaches the stable phase. That typically happens 12 to 18 months after symptoms start. Operating too early risks correcting a curve that is still changing shape on its own.
Doctors split the condition into two clear stages. The acute phase brings pain, inflammation, and a curve that keeps shifting. The stable phase means the curve has stopped moving and pain has faded. That distinction isn’t a minor detail. It decides whether a patient qualifies for injections, waits it out, or heads toward the operating room.
What Collagenase Injections Can and Cannot Fix
The FDA approved a collagenase drug, sold under the brand name Xiaflex, for men with a palpable plaque and curvature of at least 30 degrees. The AUA guideline narrows that further. It supports the injections, paired with manual modeling, for stable disease with curvature between 30 and 90 degrees and intact erectile function. Men outside that window are not good candidates.
Safety rules around this drug are strict for good reason. The FDA requires it to be given only through a restricted program because of the risk of corporal rupture, a serious penile injury. That restriction isn’t red tape for its own sake. It reflects a real complication that can happen when a powerful enzyme breaks down scar tissue inside a confined space. Patients deserve that caution, not a rushed prescription.
Traction Devices and the Case for Patience
Mayo Clinic’s urology team describes penile traction therapy as a strong option usable in both the acute and chronic phases of the disease. These devices gently stretch the penis over time to limit curvature and preserve length. They carry far less risk than injections or surgery, which makes them a reasonable starting point for men still in the active, changing phase of their condition.
Research also suggests traction works even better when combined with other treatments. Studies on pairing traction with collagenase injections found curvature correction improved by an additional 5 to 10 percent compared with injections alone. That combination approach reflects where urology is headed: layering lower-risk tools together before reaching for a scalpel, and reserving injections or surgery for men who need more aggressive correction.
When Surgery Becomes the Right Call
Surgery remains the most rapid and reliable way to straighten the penis once disease has stabilized. The AUA guideline ties surgical candidacy directly to that stable phase, not to how severe the curve looks on day one. Men with preserved erectile function typically get plication or grafting procedures. Men whose erectile function has already failed despite medical therapy are usually steered toward a penile prosthesis instead.
None of these options exist in a vacuum. The AUA, the FDA, and clinics like Mayo each emphasize different pieces of the same puzzle: disease phase, curvature degree, and erectile function. Patients who understand that framework walk into a urologist’s office asking sharper questions. That’s the real value here. Clear staging beats guesswork, and guesswork is what happens when embarrassment keeps men from asking sooner.
Sources:
menshealth.com, auanet.org, accessdata.fda.gov, uhcprovider.com
